MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 220 filers reported holding MYRIAD GENETICS INC in Q2 2024. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JET CAPITAL INVESTORS L P | 1,571,600 | $42,229,000 | 3.01% |
| MUHLENKAMP & CO INC | 481,900 | $12,949,000 | 2.70% |
| S&T BANK/PA | 420,601 | $11,302,000 | 1.98% |
| TRAXIS PARTNERS LP | 80,000 | $2,150,000 | 1.66% |
| MAZAMA CAPITAL MANAGEMENT INC | 95,346 | $2,562,000 | 1.59% |
| JAY JEFFREY R | 70,000 | $1,881,000 | 1.49% |
| Palisades Investment Partners, LLC | 48,100 | $1,292,000 | 1.28% |
| TIVERTON ASSET MANAGEMENT LLC | 1,780,200 | $47,837,000 | 1.24% |
| TEALWOOD ASSET MANAGEMENT INC | 90,785 | $2,439,000 | 1.22% |
| NEW AMSTERDAM PARTNERS LLC/NY | 812,656 | $21,836,000 | 1.16% |